Scientific journal retracts three papers on MDMA use in therapy

Over the weekend the journal Psychopharmacology retracted three papers about MDMA-assisted therapy due to protocol violations and ethics concerns. This retraction comes just days after the Food and Drug Administration rejected the use of the psychedelic drug to treat post-traumatic stress disorder.

Here & Now‘s Lisa Mullins talks with Meghana Keshavan from our partners at STAT about the retraction, the FDA decision, and what they mean for the future efforts to research psychedelic drug use in therapy.

This article was originally published on WBUR.org.